Industry

Global Hormone Therapy Market Report 2024 Insights, Industry Size, Competitive Strategies, Advertising Trends And Forecast To 2033 | Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA.

The Hormone Therapy by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Hormone Therapy Market:
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

The landscape of hormone therapy, as delineated by The Business Research Company, illustrates a robust trajectory in recent years. From its standing at $18.58 billion in 2024, the market is poised to ascend to $19.93 billion by the same year, boasting a compound annual growth rate (CAGR) of 7.3%. This growth stems from multifaceted factors including medical breakthroughs, a paradigm shift in women’s health paradigms, heightened awareness, vigorous clinical research, and evolving healthcare modalities.

Projections indicate a continuation of this upward trajectory, with the market projected to burgeon to $26.49 billion by 2028, showcasing a CAGR of 7.4%. This anticipated surge is underpinned by the embrace of personalized medicine, demographic shifts marked by an aging populace, redefined approaches to women’s health, an accentuation on wellness, longevity, and responsive regulatory frameworks. Forecasts also spotlight pivotal trends encompassing regulatory adaptations, lifestyle modifications, intensified research endeavors, and an augmented focus on education and awareness.

A surge in the incidences of hormone imbalance disorders is significantly contributing to the growth of the hormone therapy market going forward. Hormone imbalance refers to the condition where the body produces either too much or too little of a hormone. Various hormone imbalance disorders include hypothyroidism, hypogonadism, growth hormone deficiency, and so on. Hormone therapies such as estrogen replacement, testosterone replacement, and insulin therapy are used to treat hormone imbalance disorders. For example, according to a 2022 report published by London Medical Laboratory, a UK-based provider of diagnostics and phlebotomy, 19% more people were expected to have significant hormone imbalances in 2022 compared to 2 years ago. Therefore, a surge in the incidence of hormone imbalance disorders will drive the hormone therapy market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9246&type=smp

The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Top 5 Major Players:

A pivotal trend in this domain is the accentuation on product innovation, which is gaining traction within the hormone therapy market. Key industry players are directing efforts towards the introduction of novel treatments targeting hormone imbalance disorders and associated symptoms. These endeavors aim to mitigate side effects while expanding therapeutic options. Noteworthy is the FDA approval in May 2021 of MYFEMBREE, a once-daily medication developed by Myovant Sciences and Pfizer. This innovation addresses excessive monthly bleeding in premenopausal women with uterine fibroids, providing significant symptom relief with a single daily dose. Additionally, the MYFEMBREE Support Program offers comprehensive assistance including insurance checks, prior authorization support, co-pay assistance, and patient aid for qualifying uninsured individuals, exemplifying a holistic approach towards patient care and support.

The hormone therapy market report table of contents includes:
1. Executive Summary
2. Hormone Therapy Market Characteristics
3. Hormone Therapy Market Trends And Strategies
4. Hormone Therapy Market – Macro Economic Scenario
5. Global Hormone Therapy Market Size and Growth

….

31. Global Hormone Therapy Market Competitive Benchmarking
32. Global Hormone Therapy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hormone Therapy Market
34. Hormone Therapy Market Future Outlook and Potential Analysis
35. Appendix

List of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

….

Table 75: Abbott Laboratories Financial Performance
Table 76: Bayer AG Financial Performance
Table 77: Eli Lilly and Company Financial Performance
Table 78: F. Hoffmann-La Roche Financial Performance
Table 79: Merck KGaA Financial Performance

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Good PR News